{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:57:48Z","timestamp":1791464268860,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.cld.2018.03.014","type":"journal-article","created":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T19:53:38Z","timestamp":1527537218000},"page":"533-544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Chronic Complications of Cholestasis"],"prefix":"10.1016","volume":"22","author":[{"given":"David N.","family":"Assis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cld.2018.03.014_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198301063080101","article-title":"The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis","volume":"308","author":"Roll","year":"1983","journal-title":"N\u00a0Engl J Med"},{"issue":"5617","key":"10.1016\/j.cld.2018.03.014_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/bmj.3.5617.515","article-title":"Chronic cholangitides: aetiology, diagnosis, and treatment","volume":"3","author":"Sherlock","year":"1968","journal-title":"Br Med J"},{"issue":"3","key":"10.1016\/j.cld.2018.03.014_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0016-5085(66)80071-9","article-title":"Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis","volume":"50","author":"Datta","year":"1966","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2018.03.014_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0016-5085(88)80029-5","article-title":"Fat-soluble vitamin nutriture in primary biliary cirrhosis","volume":"95","author":"Kaplan","year":"1988","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.cld.2018.03.014_bib5","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1111\/j.1572-0241.2001.04134.x","article-title":"Fat-soluble vitamin levels in patients with primary biliary cirrhosis","volume":"96","author":"Phillips","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2018.03.014_bib6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2036.2000.00729.x","article-title":"Plasma antioxidant levels in chronic cholestatic liver diseases","volume":"14","author":"Floreani","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.cld.2018.03.014_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/hep.1840080126","article-title":"Impaired release of vitamin A from liver in primary biliary cirrhosis","volume":"8","author":"Nyburg","year":"1988","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2018.03.014_bib8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/MPG.0b013e31825c9732","article-title":"Oral absorbable fat-soluble vitamin formulation in pediatric patients with cholestasis","volume":"55","author":"Shen","year":"2012","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.cld.2018.03.014_bib9","doi-asserted-by":"crossref","first-page":"e607","DOI":"10.1542\/peds.2011-1423","article-title":"Efficacy of fat-soluble vitamin supplementation in infants with biliary atresia","volume":"130","author":"Schneider","year":"2012","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.cld.2018.03.014_bib10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2018.03.014_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4065\/73.3.285","article-title":"Idiopathic adult ductopenia: an update","volume":"73","author":"Ludwig","year":"1998","journal-title":"Mayo Clin Proc"},{"issue":"2 Pt 1","key":"10.1016\/j.cld.2018.03.014_bib12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0016-5085(89)91574-6","article-title":"Intestinal malabsorption of vitamin E in primary\u00a0biliary cirrhosis","volume":"96","author":"Sokol","year":"1989","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2018.03.014_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1590-8658(03)00078-1","article-title":"Osteoporosis: still a typical complication of primary biliary cirrhosis?","volume":"35","author":"Solerio","year":"2003","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2018.03.014_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1297-319X(02)00364-0","article-title":"Bone loss in primary biliary cirrhosis: absence of association with severity of liver disease","volume":"69","author":"Le Gars","year":"2002","journal-title":"Joint Bone Spine"},{"issue":"4","key":"10.1016\/j.cld.2018.03.014_bib15","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jhep.2004.11.035","article-title":"Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis","volume":"42","author":"Gua\u00f1abens","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2018.03.014_bib16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.1840140215","article-title":"Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis","volume":"14","author":"Eastell","year":"1991","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2018.03.014_bib17","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1172\/JCI117959","article-title":"Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice","volume":"95","author":"Janes","year":"1995","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1016\/j.cld.2018.03.014_bib18","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/liv.12153","article-title":"Ursodeoxycholic acid increases differentiation and mineralization and neutralizes the damaging effects of bilirubin on osteoblastic cells","volume":"33","author":"Dubreuil","year":"2013","journal-title":"Liver Int"},{"issue":"12","key":"10.1016\/j.cld.2018.03.014_bib19","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/eci.12355","article-title":"Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis","volume":"44","author":"Ruiz-Gasp\u00e0","year":"2014","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"10.1016\/j.cld.2018.03.014_bib20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2036.2004.02089.x","article-title":"Fracture risk of women with primary biliary cirrhosis: no increase compared with general population controls","volume":"20","author":"Boulton-Jones","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.cld.2018.03.014_bib21","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1053\/j.gastro.2010.02.016","article-title":"Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis","volume":"138","author":"Gua\u00f1abens","year":"2010","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2018.03.014_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2018.03.014_bib23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.1840040215","article-title":"Intestinal calcium absorption and vitamin D status in chronic cholestatic liver disease","volume":"4","author":"Bengoa","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2018.03.014_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2017-315242","article-title":"Calcium and vitamin D supplementation and increased risk of serrated polyps: results from a randomised clinical trial","author":"Crockett","year":"2018","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.cld.2018.03.014_bib25","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1111\/j.1572-0241.2003.07639.x","article-title":"Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis","volume":"98","author":"Gua\u00f1abens","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2018.03.014_bib26","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1002\/hep.26466","article-title":"Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis","volume":"58","author":"Gua\u00f1abens","year":"2013","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2018.03.014_bib27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/MJT.0b013e3181d7e1d3","article-title":"Parenteral bisphosphonates for osteoporosis in patients with primary biliary cirrhosis","volume":"18","author":"Treeprasertsuk","year":"2011","journal-title":"Am J Ther"},{"issue":"3","key":"10.1016\/j.cld.2018.03.014_bib28","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4065\/77.3.262","article-title":"Upper gastrointestinal tract safety of risedronate: a pooled analysis of 9 clinical trials","volume":"77","author":"Taggart","year":"2002","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.cld.2018.03.014_bib29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1053\/gast.2000.16517","article-title":"Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women","volume":"119","author":"Lanza","year":"2000","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2018.03.014_bib30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/gut.51.2.265","article-title":"Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis","volume":"51","author":"Longo","year":"2002","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cld.2018.03.014_bib31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hep.1840180117","article-title":"Decrease of hepatic triglyceride lipase levels and increase of cholesteryl ester transfer protein levels in patients with primary biliary cirrhosis: relationship to abnormalities in high-density lipoprotein","volume":"18","author":"Hiraoka","year":"1993","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2018.03.014_bib32","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/0016-5085(85)90642-0","article-title":"Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification","volume":"89","author":"Jahn","year":"1985","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.cld.2018.03.014_bib33","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1136\/gut.2005.079814","article-title":"Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis","volume":"55","author":"Allocca","year":"2006","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.cld.2018.03.014_bib34","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1572-0241.2008.01888.x","article-title":"Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis","volume":"103","author":"Floreani","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.cld.2018.03.014_bib35","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1194\/jlr.M400229-JLR200","article-title":"Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation","volume":"45","author":"Chang","year":"2004","journal-title":"J\u00a0Lipid Res"},{"issue":"4","key":"10.1016\/j.cld.2018.03.014_bib36","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0168-8278(02)00006-5","article-title":"Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers","volume":"36","author":"Ritzel","year":"2002","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2018.03.014_bib37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.atherosclerosis.2009.08.052","article-title":"Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment","volume":"209","author":"Sjotakovic","year":"2010","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.cld.2018.03.014_bib38","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/liv.12191","article-title":"Randomized controlled trial assessing the effect of simvastatin in primary biliary cirrhosis","volume":"33","author":"Cash","year":"2013","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.cld.2018.03.014_bib39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ajg.2017.287","article-title":"Effects of bezafibrate on outcome and pruritus in primary biliary cholangitis with suboptimal ursodeoxycholic acid response","volume":"113","author":"Reig","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"1, Suppl","key":"10.1016\/j.cld.2018.03.014_bib40","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S0168-8278(17)30442-7","article-title":"A\u00a02-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate response to ursodeoxycholic acid therapy (Bezurso)","volume":"66","author":"Corpechot","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2018.03.014_bib41","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.27744","article-title":"Fibrates and cholestasis","volume":"62","author":"Ghonem","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2018.03.014_bib42","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.gastro.2014.12.005","article-title":"Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid","volume":"148","author":"Hirschfield","year":"2015","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.cld.2018.03.014_bib43","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A\u00a0placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2018.03.014_bib44","article-title":"Evolving role of obeticholic acid in primary biliary cholangitis","author":"Levy","year":"2017","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cld.2018.03.014_bib45","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gut.12.10.830","article-title":"Portal hypertension in primary biliary cirrhosis","volume":"12","author":"Kew","year":"1971","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.cld.2018.03.014_bib46","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/0016-5085(89)90526-X","article-title":"Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival","volume":"96","author":"Gores","year":"1989","journal-title":"Gastroenterology"},{"issue":"4 Pt 1","key":"10.1016\/j.cld.2018.03.014_bib47","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(92)90771-P","article-title":"Nodular regenerative hyperplasia of the liver in early histological stages of primary biliary cirrhosis","volume":"102","author":"Colina","year":"1992","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.cld.2018.03.014_bib48","doi-asserted-by":"crossref","DOI":"10.1097\/MCG.0b013e3181f18c4e","article-title":"Varices in early histological stage primary biliary cirrhosis","volume":"45","author":"Ali","year":"2011","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"7","key":"10.1016\/j.cld.2018.03.014_bib49","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cgh.2007.02.031","article-title":"Prevalence and predictors of esophageal varices in patients with primary biliary cirrhosis","volume":"5","author":"Levy","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2018.03.014_bib50","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/gut.2004.040832","article-title":"Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection?","volume":"54","author":"Bressler","year":"2005","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.cld.2018.03.014_bib51","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2018.03.014_bib52","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.510260508","article-title":"Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes","volume":"26","author":"Jones","year":"1997","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2018.03.014_bib53","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/gutjnl-2014-308351","article-title":"Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study","volume":"65","author":"Trivedi","year":"2016","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cld.2018.03.014_bib54","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326118300394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326118300394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T14:23:51Z","timestamp":1571408631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326118300394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1089326118300394"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2018.03.014","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Complications of Cholestasis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2018.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}